Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 23CNS 6Gynecologic 5Genitourinary 4Gastrointestinal 4Thoracic 2Other solid neoplasm 2Head & Neck 2Breast 2

Conditions

Small Cell Lung Carcinoma 16Carcinoma, Non-Small-Cell Lung 16Lung Neoplasms 14Neoplasm Metastasis 7Brain Neoplasms 7Sarcoma 2Melanoma 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Carcinoma, Small Cell 2Breast Neoplasms 2Adenocarcinoma of Lung 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Cancer Recurrent 1SCLC, Extensive Stage 1Recurrent Extensive Stage Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Non Small Cell Lung Cancer Metastatic 1Neuroendocrine Tumors 1Neoplasms, Second Primary 1Mesothelioma 1Extensive Stage Small Cell Lung Cancer 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Neuroendocrine 1Carcinoma, Large Cell 1Carcinoma 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

pembrolizumab 11Cyclophosphamide 8Gemcitabine 7Cisplatin 7tislelizumab 5Docetaxel 5Nivolumab 4Injections 4spartalizumab 3regorafenib 3Trastuzumab 3Oncolytic Virotherapy 3Irinotecan 3Filgrastim 3Drug Therapy 3Doxorubicin 3Carboplatin 3Bortezomib 3tazemetostat 2pazopanib 2liposomal doxorubicin 2ganitumab 2conatumumab 2belinostat 2Temozolomide 2Taxes 2Tamoxifen 2Sorafenib 2Riluzole 2Radiotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma × Temozolomide × Thoracic × Clear all
NCT00629343 2025-06-05

Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

Columbia University

Phase 1 Completed
27 enrolled 7 charts
Other solid neoplasmSarcomaThoracic

Mesothelioma, Sarcoma

NCT03150810 2024-12-20

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

BeiGene

Phase 1 Completed
139 enrolled 36 charts
BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡